Overview
- 29 inspections across 29 sites are on record.
- 60 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-10-29.
At a glance
Inspections
29
Sites
29
Observations
60
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| New Vision Pharmaceuticals LLC | 29 Oct 2021 | Human Drugs | On file |
| Frontida Biopharm, LLC | 26 Feb 2021 | Human Drugs | |
| Dental Technologies, Inc. | 20 Jan 2021 | Human Drugs | On file |
| Zydus Lifesciences Limited | 9 Mar 2020 | Human Drugs | |
| Mylan Laboratories Limited | 28 Feb 2020 | Human Drugs |
Sites inspected
New Vision Pharmaceuticals LLCTamarac, United States1 insp.
Frontida Biopharm, LLCAurora, United States1 insp.
Dental Technologies, Inc.Lincolnwood, United States1 insp.
Zydus Lifesciences LimitedSolan, India1 insp.
Mylan Laboratories LimitedAurangabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Brian D Nicholson4 shared
Jason R Caballero3 shared
Christopher R Czajka3 shared
Joan M Cantellops Figueroa2 shared
John A Gonzalez2 shared
Kenneth H Williams2 shared
Vioela Respress1 shared
Nibin Varghese1 shared
Michele L Glendenning1 shared
Norman K Starks1 shared
Full investigator report
Get the verbatim findings behind Vioela J Caze's 60 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site